Natera, Inc.

(NASDAQ GS: NTRA)

Rigrodsky Law, P.A. is investigating Natera, Inc. (“Natera” or the "Company”) and certain of its officers for issuing materially false and misleading statements during the Class Period (February 26, 2020 and April 19, 2022, inclusive) concerning the Company’s non-invasive prenatal test, Panorama, and Natera’s screening test for kidney transplant failure, Prospera, in possible violation of the federal securities laws.

Join This Action

First Name*

Last Name*

Email Address*

Mailing Address*

City*

State/Province*

Zip/Postal Code*

Phone*

Number of Shares Purchased

Date(s) Shares Purchased

Purchase Price Per Share

Number of Shares Sold

Date(s) Shares Sold

Sale Price Per Share

Comments

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Select files

By signing and clicking the Submit button below, I hereby execute the Retention Agreement and, upon execution of the Retention Agreement by Rigrodsky Law, P.A., retain Rigrodsky Law, P.A. to bring a lawsuit on my behalf pursuant to the terms set forth in the Retention Agreement, which is incorporated herein by reference.*

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 07/06/2022

X Code

* Indicates a required field.